Accounts Receivable	9 Months Ended
	Sep. 30, 2020
Receivables [Abstract]
Accounts Receivable	Accounts Receivable    As of September 30, 2020 and December 31, 2019, the Company had accounts receivable of $8.6 million and $7.2 million respectively, which primarily relates to royalty revenue from sales of NARCAN®.